Fmr LLC lifted its holdings in shares of UnitedHealth Group Inc (NYSE:UNH) by 2.6% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 63,247,814 shares of the healthcare conglomerate’s stock after purchasing an additional 1,625,459 shares during the quarter. UnitedHealth Group accounts for 1.9% of Fmr LLC’s holdings, making the stock its 6th largest position. Fmr LLC owned 6.57% of UnitedHealth Group worth $16,826,448,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds have also made changes to their positions in UNH. Cornerstone Wealth Management LLC lifted its holdings in UnitedHealth Group by 24,755.2% in the 2nd quarter. Cornerstone Wealth Management LLC now owns 245,569 shares of the healthcare conglomerate’s stock valued at $992,000 after purchasing an additional 244,581 shares in the last quarter. Advisory Services Network LLC lifted its holdings in UnitedHealth Group by 29.9% in the 2nd quarter. Advisory Services Network LLC now owns 7,494 shares of the healthcare conglomerate’s stock valued at $1,926,000 after purchasing an additional 1,724 shares in the last quarter. Summit Securities Group LLC purchased a new position in UnitedHealth Group in the 2nd quarter valued at $981,000. Provident Trust Co. lifted its holdings in UnitedHealth Group by 2.4% in the 2nd quarter. Provident Trust Co. now owns 953,443 shares of the healthcare conglomerate’s stock valued at $233,918,000 after purchasing an additional 22,367 shares in the last quarter. Finally, Glenview State Bank Trust DEPT. lifted its holdings in UnitedHealth Group by 29.6% in the 2nd quarter. Glenview State Bank Trust DEPT. now owns 2,821 shares of the healthcare conglomerate’s stock valued at $693,000 after purchasing an additional 645 shares in the last quarter. 85.45% of the stock is currently owned by institutional investors.
NYSE UNH opened at $281.36 on Monday. UnitedHealth Group Inc has a 52 week low of $208.48 and a 52 week high of $285.45. The company has a debt-to-equity ratio of 0.61, a quick ratio of 0.69 and a current ratio of 0.69. The firm has a market cap of $270.68 billion, a PE ratio of 27.94, a P/E/G ratio of 1.62 and a beta of 0.78.
UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Tuesday, October 16th. The healthcare conglomerate reported $3.41 EPS for the quarter, topping the consensus estimate of $3.30 by $0.11. UnitedHealth Group had a return on equity of 23.62% and a net margin of 5.71%. The business had revenue of $56.56 billion for the quarter, compared to analyst estimates of $56.34 billion. During the same quarter in the previous year, the firm earned $2.66 EPS. The company’s quarterly revenue was up 12.4% compared to the same quarter last year. Sell-side analysts expect that UnitedHealth Group Inc will post 12.82 earnings per share for the current fiscal year.
The business also recently declared a quarterly dividend, which will be paid on Thursday, December 13th. Stockholders of record on Monday, December 3rd will be issued a dividend of $0.90 per share. The ex-dividend date is Friday, November 30th. This represents a $3.60 annualized dividend and a dividend yield of 1.28%. UnitedHealth Group’s dividend payout ratio is presently 35.75%.
A number of research analysts have weighed in on UNH shares. Citigroup lowered UnitedHealth Group from a “buy” rating to a “neutral” rating and set a $288.00 price objective on the stock. in a report on Monday, September 10th. Zacks Investment Research lowered UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Tuesday, September 18th. Raymond James raised their price objective on UnitedHealth Group from $285.00 to $304.00 and gave the company a “strong-buy” rating in a report on Monday, September 24th. Bank of America raised their price objective on UnitedHealth Group from $315.00 to $320.00 and gave the company a “buy” rating in a report on Wednesday, October 17th. Finally, Morgan Stanley raised their price objective on UnitedHealth Group from $278.00 to $305.00 and gave the company an “overweight” rating in a report on Wednesday, September 5th. Two equities research analysts have rated the stock with a hold rating and twenty-one have assigned a buy rating to the company’s stock. UnitedHealth Group presently has an average rating of “Buy” and a consensus price target of $292.48.
In related news, Director Richard T. Burke sold 6,090 shares of the firm’s stock in a transaction dated Wednesday, November 28th. The stock was sold at an average price of $281.72, for a total transaction of $1,715,674.80. Following the completion of the sale, the director now directly owns 1,711,584 shares of the company’s stock, valued at approximately $482,187,444.48. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Steven H. Nelson sold 26,033 shares of the firm’s stock in a transaction dated Friday, September 7th. The stock was sold at an average price of $270.65, for a total value of $7,045,831.45. The disclosure for this sale can be found here. In the last quarter, insiders have sold 60,428 shares of company stock worth $16,232,134. Insiders own 0.87% of the company’s stock.
UnitedHealth Group Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Further Reading: Asset Allocation and Your Retirement
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.